Latest Innovation News

Algorae Pharmaceuticals has secured a $384,466 cash refund from the Australian Taxation Office, reinforcing its financial position to advance AI-driven drug discovery programs.

Cogstate Ltd reports a near doubling in sales contracts for the first half of 2026 but warns of timing-related revenue deferrals that will temper short-term earnings. Despite this, management remains optimistic about medium- and long-term growth prospects.

Meteoric Resources has successfully produced its inaugural batch of Mixed Rare Earth Carbonate at its Caldeira Pilot Plant in Brazil, marking a significant milestone in its rare earths project development.

Ampol Limited reports solid first-half 2025 results, highlights a strengthening refinery margin, and advances its strategic acquisition of EG Australia, aiming to reshape its retail footprint and cost base.

PWR Holdings has appointed Sharyn Williams as its new CEO and Managing Director, marking a strategic leadership transition while the search for a new CFO is underway.

Spenda Limited has successfully raised $1.4 million through a private placement, attracting both new and existing sophisticated investors to support its product development and working capital needs.

VBX Limited has confirmed the quality and scale of its Wuudagu C bauxite deposit through comprehensive infill drilling, reinforcing its Preliminary Feasibility Study and advancing its Definitive Feasibility Study with metallurgical optimization.

Stellar Resources has reported robust metallurgical test results from its Severn Deposit, highlighting strong tin recoveries and production of a clean, high-grade concentrate. These findings reinforce the project’s potential as a low-cost, high-quality tin source in a stable jurisdiction.

InhaleRx Limited has secured $427,500 from an initial tranche of its $1 million capital raise, issuing 17.1 million shares to support its inhaled therapies targeting pain and mental health conditions.

Carnegie Clean Energy’s Spanish subsidiary has received a significant pre-financing payment from the European Commission to advance innovations in wave energy technology through the COIN Project.

Emeco Group reveals a robust FY25 with $785 million revenue, nearly half from its expanding maintenance services, underpinned by advanced asset management technology and a strategic push into new sectors.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.